MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jncics/pkag110

Медицинская библиотека · JNCI cancer spectrum · 2026

COVID-19 and thrombotic risk in patients with active cancer: a matched cohort study.

Doyen Jérôme, Lacour Alexandre, Schiappa Renaud, Seutin Eva, Garrido Amanda, Loscos Tanguy Pace, Doyen Denis

СтатьяПеревод пока не подготовлен

Аннотация

COVID-19 has been associated with an increased thrombotic risk, potentially exacerbated in patients with active cancer. We conducted a retrospective cohort study including 119 cancer patients with COVID-19 and 214 matched pre-pandemic controls. Patients with COVID-19 had poorer performance status and were more frequently treated with palliative intent. After a median follow-up of 32.7 months, overall thrombotic event rates did not differ between groups. However, after adjustment for clinically relevant covariates and accounting for death as a competing event, COVID-19 status and palliative treatment intent remained independently associated with a higher cumulative incidence of thrombotic events. In conclusion, COVID-19 may increase thrombotic risk in patients with cancer and occurs more frequently in patients with poorer clinical status. These findings are exploratory and require confirmation in larger prospective studies.

Для цитирования: Doyen Jérôme, Lacour Alexandre, Schiappa Renaud, Seutin Eva, Garrido Amanda, Loscos Tanguy Pace, Doyen Denis. COVID-19 and thrombotic risk in patients with active cancer: a matched cohort study.. JNCI cancer spectrum. 2026. DOI: 10.1093/jncics/pkag110.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.